Global Fertility Services Market Grows Steadily at a CAGR of 8.2%

Introduction

Fertility services encompass a comprehensive range of medical and supportive interventions designed to assist individuals and couples in achieving pregnancy. These services include diagnostics, such as hormone testing, semen analysis, and imaging studies, which help identify underlying fertility issues. Treatment options encompass various methods, including in vitro fertilization (IVF), artificial insemination (IUI), egg and sperm donation, and gestational surrogacy, each tailored to address specific fertility challenges.

Market Dynamics

A surge in demand for assisted reproductive technology

The rising demand for assisted reproductive technology (ART), such as IVF, IUI, and IVF without ICSI, is a key growth driver in the global fertility services market. This increase is largely fueled by factors like delayed parenthood, greater awareness of fertility treatments, and significant technological advancements. Changing societal attitudes toward fertility treatments and the increasing need for family planning further boost ART’s popularity.

• For example, the American Society for Reproductive Medicine reported that 91,771 babies were born through IVF in 2022, making up 2.5% of all U.S. births. This reflects the growing reliance on ART as a solution for infertility. Likewise, more countries are expanding insurance coverage and policy support for ART, improving access to these services and driving further growth.

Reducing multiple birth risks through advanced fertility treatment technologies

Reducing multiple birth risks through advanced fertility treatment technologies opens significant opportunities in the fertility services market. A major challenge in treatments like IVF is the increased likelihood of multiple pregnancies, which can pose health risks for both mother and children.

However, innovations such as single embryo transfer (SET), Preimplantation Genetic Testing (PGT), and AI-driven embryo selection enable precise embryo selection. These technologies help reduce the need for multiple embryo transfers, thereby significantly lowering the risk of multiple pregnancies while improving success rates and patient safety.

By investing in these advancements, companies can offer safer and more personalized fertility solutions, appealing to a broader patient base concerned about the risks associated with multiple births. Moreover, by promoting the benefits of such technologies, fertility service providers can differentiate themselves in a competitive market, establishing themselves as leaders in offering high-quality, ethical treatment options.

Regional Analysis

North America is the most significant global fertility services market shareholder. The growth is attributed to a robust healthcare infrastructure that facilitates access to advanced fertility treatments. The significant demand for these services is largely driven by shifting societal trends, including delayed family planning and increased awareness of available fertility options. Moreover, government initiatives and insurance coverage for treatments such as in vitro fertilization (IVF) have further enhanced accessibility for individuals and couples seeking assistance.

The Asia Pacific region is experiencing a rapid growth rate in the market. Key players such as India, China, and Japan are at the forefront of this expansion, witnessing an increase in the number of fertility clinics and greater access to advanced treatments like in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Favorable government policies, including relaxed regulations on fertility treatments and subsidies to support patients, are further driving the rapid growth of this market.

Key Highlights

• The global fertility services market size was valued at USD 45.52 billion in 2024 and is projected to reach from USD 48.94 billion in 2025 to USD 87.31 billion by 2033, exhibiting a CAGR of 8.2% during the forecast period (2025-2033).

• Based on procedure, the global fertility services market is divided into in vitro fertilization with intracytoplasmic sperm injection (IVF with ICSI), intrauterine insemination (IUI), in vitro fertilization without intracytoplasmic sperm injection (IVF without ICSI), surrogacy, and others. The in vitro fertilization with intracytoplasmic sperm injection (ICSI) segment owns the highest market share.
• Based on service, the global fertility services market is segmented into fresh non-donor, frozen non-donor, egg & embryo banking, fresh donor, and frozen donor. The fresh non-donor segment is the largest revenue contributor to the market.
• Based on end-users, the market is segmented into fertility clinics, hospitals, surgical centers, and clinical research institutes. The fertility clinics segment is the largest revenue contributor to the market.
• North America is the most significant global fertility services market shareholder.

Competitive Players

1. Merck KGaA
2. Apollo Hospitals Enterprise Ltd.
3. Care Fertility Group Ltd.
4. Carolinas Fertility Institute
5. City Fertility
6. Fertility Associates Limited
7. Genea Limited
8. Medicover Group
9. Monash IVF Group Limited
10. Progyny Inc.
11. Virtus Health
12. Pacific Fertility Center of Los Angeles (PFCLA)
13. Mayo Foundation for Medical Education and Research (MFMER)
14. Cleveland Clinic
15. Apricity Fertility UK Limited
16. King’s Fertility Limited
17. Fertility

Recent Developments

• In August 2024, Alchemist-Ojas Hospital in Panchkula launched its advanced infertility treatment and IVF services, offering state-of-the-art technology and personalized care. The facility is equipped to provide comprehensive fertility treatments, catering to couples facing challenges in conceiving. The hospital aims to bring high-quality and affordable fertility care to the region, addressing the growing demand for such services.

Analyst Opinion

As per our analyst, the global fertility services market presents significant growth opportunities to companies that leverage advance technologies to improve success rates and differentiate from competitors. Companies looking to gain the largest market share should implement flexible financing options to make treatments more accessible and expand into underserved regions, utilizing telehealth to increase patient reach.

Addressing ethical concerns by limiting embryo transfers to reduce multiple pregnancy risks and ensuring compliance with evolving regulations is also a key factor for the growth. Companies should consider strategic partnerships or consolidation to achieve operational efficiencies while maintaining high-quality care. These strategies will help them gain a competitive advantage and sustainable growth in the fertility sector.

Segmentation

1. By Procedure
   1. In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)
   2. Intrauterine Insemination (IUI)
   3. In Vitro Fertilization without Intracytoplasmic Sperm Injection (IVF without ICSI)
   4. Surrogacy
   5. Others
2. By Service
   1. Fresh Non-donor
   2. Frozen Non-donor
   3. Egg & Embryo Banking
   4. Fresh Donor
   5. Frozen Donor
3. By End-User
   1. Fertility Clinics
   2. Hospitals
   3. Surgical Centers
   4. Clinical Research Institutes
4. By Regions
   1. North America
   2. Europe
   3. Asia-Pacific
   4. Latin America
   5. The Middle East and Africa